Philadelphia is no longer a U.S. headquarters for British drugmaker GlaxoSmithKline P.L.C., the company announced yesterday. As part of a restructuring that will eliminate 1,800 U.S. sales jobs, GlaxoSmithKline said it would designate its facilities in Research Triangle Park, N.C., as the single operational headquarters for the United States.